Balazs Sumegi Selected Research

Balazs Sumegi Research Topics

Disease

13	Neoplasms (Cancer) 04/2020 - 03/2002
9	Heart Failure 01/2021 - 07/2006
9	Ischemia 01/2013 - 12/2002
8	Inflammation (Inflammations) 01/2019 - 07/2004
6	Hypertrophy 01/2021 - 07/2006
5	Hypertension (High Blood Pressure) 01/2021 - 01/2013
5	Necrosis 01/2017 - 10/2005
4	Fibrosis (Cirrhosis) 01/2017 - 07/2006
4	Cardiomegaly (Heart Hypertrophy) 01/2017 - 07/2006
3	Disease Progression 01/2021 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2009
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 02/2009
3	Septic Shock (Toxic Shock Syndrome) 02/2009 - 04/2003
3	Infarction (Infarctions) 09/2006 - 12/2003
2	Endotoxemia 01/2021 - 12/2015
2	Shock 01/2021 - 07/2004
2	Sepsis (Septicemia) 01/2021 - 12/2015
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2018 - 01/2017
2	Vascular Remodeling 01/2017 - 07/2014
2	Glioblastoma (Glioblastoma Multiforme) 12/2014 - 01/2013
2	Cardiotoxicity 06/2012 - 01/2005
2	Cardiomyopathies (Cardiomyopathy) 10/2011 - 01/2005
2	Leiomyoma (Uterine Fibroids) 09/2010 - 02/2007
2	Carcinoma (Carcinomatosis) 02/2009 - 03/2003
2	Myocardial Infarction 09/2008 - 07/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Systolic Heart Failure 11/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Retinal Diseases 01/2019
1	Pulmonary Arterial Hypertension 01/2018
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 01/2018
1	Insulin Resistance 01/2018
1	Glioma (Gliomas) 01/2017
1	Acute Lung Injury 12/2015
1	Lung Injury 12/2015

Drug/Important Bio-Agent (IBA)

19	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2020 - 04/2003
12	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2020 - 04/2003
11	Phosphotransferases (Kinase)IBA 02/2020 - 07/2004
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2002
7	EnzymesIBA 04/2020 - 04/2003
6	Pharmaceutical PreparationsIBA 01/2021 - 07/2006
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2004
5	BGP 15IBA 01/2021 - 03/2002
5	LipopolysaccharidesIBA 01/2021 - 04/2003
5	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 04/2003
5	2- ((2- piperidin- 1- ylethyl)thio)quinazolin- 4(3H)- oneIBA 01/2017 - 07/2006
4	desethylamiodaroneIBA 01/2020 - 11/2003
4	Cytostatic AgentsIBA 01/2019 - 04/2009
4	p38 Mitogen-Activated Protein KinasesIBA 01/2017 - 01/2014
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2017 - 07/2006
3	CollagenIBA 01/2021 - 07/2006
3	ResveratrolIBA 11/2020 - 05/2013
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2019 - 07/2004
3	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2019 - 04/2003
3	EndotoxinsIBA 12/2015 - 04/2003
3	Mitogen-Activated Protein KinasesIBA 12/2014 - 07/2006
3	Transcription Factors (Transcription Factor)IBA 07/2014 - 07/2004
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 10/2011
3	Adenosine Triphosphate (ATP)IBA 06/2012 - 10/2005
3	Phosphates (Orthophosphate)IBA 06/2012 - 12/2002
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 05/2012 - 04/2003
3	PolyphenolsIBA 01/2011 - 02/2009
3	Glycogen Synthase Kinase 3 betaIBA 09/2008 - 02/2006
3	NAD (NADH)IBA 02/2006 - 12/2002
3	AntioxidantsIBA 01/2005 - 04/2003
2	Cyclophilins (Cyclophilin)IBA 01/2021 - 12/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 05/2013
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2002
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2017 - 12/2002
2	Oxygen (Dioxygen)IBA 01/2017 - 12/2015
2	Protein Isoforms (Isoforms)IBA 08/2016 - 01/2014
2	CytokinesIBA 12/2015 - 01/2014
2	Small Heat-Shock ProteinsIBA 01/2015 - 12/2007
2	NF-kappa B (NF-kB)IBA 07/2014 - 07/2004
2	LipidsIBA 01/2013 - 03/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011 - 01/2005
2	ferulaldehydeIBA 01/2011 - 02/2009
2	Apoptosis Inducing FactorIBA 03/2010 - 11/2003
2	Protein Kinase CIBA 06/2009 - 07/2006
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2006 - 07/2004
2	WortmanninIBA 02/2006 - 12/2003
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Therapeutic UsesIBA 04/2020
1	Retinaldehyde (Retinal)IBA 01/2019
1	olaparibIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Hydroxylamine (Hydroxylamine Hydrochloride)IBA 01/2018
1	GTP Phosphohydrolases (GTPases)IBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	NitrogenIBA 12/2015
1	NitritesIBA 06/2015

Therapy/Procedure

14	Therapeutics 11/2020 - 01/2009